Verde Technologies debuts Rx disposal system

MINNEAPOLIS — Verde Technologies this week is debuting its Deterra Drug Deactivation System, a self-contained pouch used to dispose of prescription medications.



The Deterra system uses patented MAT12 Molecular Adsorption Technology to deactivate unwanted and unneeded opioids, antibiotics, transdermal patches and other prescription drugs, rendering them ineffective for misuse and safe for the environment, according to the company. The Deterra system features a pouch containing MAT12, a proprietary activated carbon that bonds to pharmaceutical compounds when water is added, rendering drugs ineffective and safe for disposal quickly in any setting – pharmacy, home, clinic or hospital.



Deterra has a 98.1% success rate in deactivating prescription drugs, according to a research study supported by the National Institute on Drug Abuse.



“Using Deterra to neutralize and safely dispose of drugs will not only help to reduce prescription drug abuse but will also reduce negative impact on the environment,” said Jason Sundby, president and CEO of Verde Technologies.



According to the company, Deterra renders chemical compounds safe for landfills. It also provides an alternative to take-back incineration programs and potentially reduces watershed contamination.